Osteocalcin Level in Gingival Clavicular Fluid During Canine Retraction in Periodontal Compromised Patients

Periodontal Diseases Clinical Trial

Official title:

Osteocalcin Level in Gingival Clavicular Fluid During Canine Retraction in Periodontal Compromised Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06102616
• Other study ID #: 12245
• Status: Completed
• Phase: N/A
• Start date: January 14, 2022
• Est. completion date: August 23, 2023

Study information

• Verified date: November 2023
• Source: Faculty of Dental Medicine for Girls
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Osteocalcin levels can be measured Gingival crevicular fluid (GCF). Changes in osteocalcin levels can provide important information about the status of bone metabolism and bone remodeling. The levels of this markers in GCF can provide information about the status of bone remodeling in the surrounding bone tissue in periodontal affected teeth.

Description:

Osteocalcin levels can be measured using a blood test or by analyzing the levels of osteocalcin in urine or saliva. Changes in osteocalcin levels can provide important information about the status of bone metabolism and bone remodeling. Osteocalcin has been found to be present in Gingival crevicular fluid (GCF), along with other bone metabolism markers such as alkaline phosphatase and tartrate-resistant acid phosphatase. The levels of these markers in GCF can provide information about the status of bone remodeling in the surrounding bone tissue. Orthodontic tooth movement is influenced by the remodelling ability of surrounding bone and soft tissue, such as PDL and gingiva. Bone remodelling occurs in coordination, requiring coupling of bone formation after resorption. Orthodontic force induces an aseptic inflammatory response, involving cytokines and chemokines. . Increased levels of osteocalcin in body fluids indicate abnormal bone turnover activity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: August 23, 2023
• Est. primary completion date: March 20, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 25 Years to 35 Years

Eligibility

Inclusion Criteria:

• Adult female patients who were seeking for orthodontic treatment with controlled previous chronic periodontitis.

• Pocket depth of more than 5 mm before receiving non-surgical periodontal treatment or/and Pocket depth of less than 4 mm after periodontal therapy.

• Sever to very sever irregularity of mandibular anterior arch according to Little's irregularity index ranging from 7 to 10 mm with acceptable oral hygiene.

• all the permanent dentition excluding third molars should be present.

• No systemic disease or history of prolonged use of medication interfering with tooth movement as corticosteroids.

Exclusion Criteria:

• Previous orthodontic treatment.

• Patients with aggressive periodontitis or Any smoking habits.

• Pregnant or lactating female patients were excluded.

Related Conditions & MeSH terms

• Periodontal Diseases

Intervention

Diagnostic Test:
• measure Osteocalcin level
in gingival crevicular fluid before and during orthodontic tooth movement

Locations

Country	Name	City	State
Egypt	faculty of dental medicine Azhar University	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Faculty of Dental Medicine for Girls

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Osteocalcin levels in gingival crevicular fluid before and during orthodontic tooth movement	ELISA test to measure osteocalcin in GCF	at baseline, then after 3 months and after 6 month